SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001140361-15-038101
Filing Date
2015-10-20
Accepted
2015-10-20 17:26:55
Documents
1
Period of Report
2015-10-14

Document Format Files

Seq Description Document Type Size
1 FORM 3 doc1.html 3  
1 FORM 3 doc1.xml 3 7544
  Complete submission text file 0001140361-15-038101.txt   9921
Mailing Address 10 ST JAMES AVENUE STE 1700 BOSTON MA 02116
Business Address 6172108300
KLARMAN SETH A (Reporting) CIK: 0000899869 (see all company filings)

State of Incorp.: MA | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 000-30929 | Film No.: 151166965

Mailing Address 10 ST JAMES AVENUE STE 1700 BOSTON MA 02116
Business Address 10 ST JAMES AVENUE STE 1700 BOSTON MA 02116 6172108300
SAK CORP (Reporting) CIK: 0001061088 (see all company filings)

State of Incorp.: MA
Type: 3 | Act: 34 | File No.: 000-30929 | Film No.: 151166966

Mailing Address 10 ST JAMES AVE SUITE 1700 BOSTON MA 02116
Business Address 10 ST JAMES AVE SUITE 1700 BOSTON MA 02116 617-210-8300
BAUPOST GROUP LLC/MA (Reporting) CIK: 0001061768 (see all company filings)

State of Incorp.: MA
Type: 3 | Act: 34 | File No.: 000-30929 | Film No.: 151166967

Mailing Address
Business Address 750 LEXINGTON AVENUE . NEW YORK NY 10022 212-531-5965
KERYX BIOPHARMACEUTICALS INC (Issuer) CIK: 0001114220 (see all company filings)

IRS No.: 134087132 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations